vTv Therapeutics Inc. (VTVT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 98.81M | 89.89M | 99.46M | 26.37M | 31.92M | 38.11M | 42.96M | 46.2M | 53.87M | 10.66M | 10.13M | 13.94M |
| Cash & Short-Term Investments | 98.09M | 88.93M | 98.5M | 25.92M | 31.06M | 36.75M | 41.57M | 45.53M | 52.26M | 9.45M | 8.24M | 12.6M |
| Cash Only | 98.09M | 88.93M | 98.5M | 25.92M | 31.06M | 36.75M | 41.57M | 45.53M | 52.26M | 9.45M | 8.24M | 12.6M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 62K | 242K | 306K | 981K | 102K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | 822.59 | - | - | 49.28 | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 722K | 961K | 112K | 93K | 115K | 85K | 1.06M | 303K | 571K | 0 | 1.87M | 1.32M |
| Total Non-Current Assets | 5K | 6K | 38K | 74K | 111K | 153K | 206K | 258K | 311K | 361K | 4.8M | 8.49M |
| Property, Plant & Equipment | 0 | 0 | 38K | 74K | 111K | 153K | 206K | 258K | 311K | 361K | 412K | 461K |
| Fixed Asset Turnover | - | - | - | - | - | 0.09x | - | - | 2.98x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.39M | 8.03M |
| Other Non-Current Assets | 5K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 98.81M | 89.9M | 99.49M | 26.45M | 32.03M | 38.27M | 43.16M | 46.46M | 54.18M | 11.02M | 14.92M | 22.43M |
| Asset Turnover | 0.39x | - | - | - | - | 0.00x | - | - | 0.03x | - | - | - |
| Asset Growth % | 208.53% | 134.93% | 130.5% | -43.07% | -40.89% | 247.3% | 189.23% | 107.16% | 87.95% | -66.85% | -57.98% | -39.37% |
| Total Current Liabilities | 6.88M | 6.64M | 10.16M | 5.29M | 4.32M | 5.2M | 6.42M | 6.99M | 8.92M | 10.62M | 10.28M | 9.29M |
| Accounts Payable | 0 | 1.13M | 9.8M | 5.22M | 4.19M | 939K | 6.23M | 0 | 0 | 4.08M | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | 14.98K | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 328K | 0 | 0 | 0 | 0 | 0 | 0 | 191K | 473K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 17K | 17K | 17K | 17K | 17K | 17K |
| Other Current Liabilities | 6.88M | 5.51M | 0 | 0 | 0 | 0 | 0 | 6.79M | 8.73M | 0 | 9.62M | 9.11M |
| Current Ratio | 14.36x | 13.54x | 9.79x | 4.98x | 7.39x | 7.34x | 6.69x | 6.61x | 6.04x | 1.00x | 0.99x | 1.50x |
| Quick Ratio | 14.36x | 13.54x | 9.79x | 4.98x | 7.39x | 7.34x | 6.69x | 6.61x | 6.04x | 1.00x | 0.99x | 1.50x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.97M | 18.82M | 18.79M | 18.75M | 18.81M | 18.77M | 18.83M | 19.04M | 19.27M | 18.95M | 19.16M | 19.54M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 32K | 79K | 125K | 169K | 213K | 256K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.97M | 152K | 18.79M | 79K | 145K | 100K | 18.8M | 288K | 481K | 110K | 278K | 619K |
| Total Liabilities | 8.85M | 25.46M | 28.95M | 24.04M | 23.13M | 23.96M | 25.25M | 26.02M | 28.2M | 29.57M | 29.43M | 28.83M |
| Total Debt | 0 | 0 | 360K | 79K | 125K | 169K | 213K | 256K | 298K | 529K | 851K | 417K |
| Net Debt | -98.09M | -88.93M | -98.14M | -25.84M | -30.93M | -36.58M | -41.36M | -45.27M | -51.96M | -8.92M | -7.39M | -12.18M |
| Debt / Equity | - | - | 0.01x | 0.03x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -4.22x | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -7137.00x | -2068.00x | - | - | - | - | - | - | -633.43x | -2134.00x | -3604.50x |
| Total Equity | 89.96M | 64.44M | 70.54M | 2.4M | 8.9M | 14.3M | 17.91M | 20.44M | 25.99M | -18.55M | -14.51M | -6.4M |
| Equity Growth % | 911.12% | 350.58% | 293.81% | -88.23% | -65.76% | 177.1% | 223.44% | 419.13% | 6269.36% | -417.67% | -289.98% | -186.66% |
| Book Value per Share | 10.68 | 7.65 | 8.76 | 0.37 | 1.35 | 2.48 | 3.28 | 3.19 | 6.27 | -8.90 | -7.12 | -3.14 |
| Total Shareholders' Equity | 89.96M | 64.44M | 70.54M | 2.76M | 7.92M | 12.2M | 15.01M | 16.48M | 20.8M | -24.68M | -25.23M | -25.28M |
| Common Stock | 39K | 39K | 39K | 32K | 32K | 32K | 32K | 30K | 30K | 27K | 1.05M | 1.05M |
| Retained Earnings | -302.56M | -326.69M | -319.55M | -310.86M | -304.81M | -299.72M | -296.08M | -291.3M | -286.12M | -281.04M | -281.19M | -280.81M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | -357K | 977K | 2.1M | 2.9M | 3.96M | 5.19M | 6.13M | 10.72M | 18.88M |